Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Financial Ratios
Add-Life Pharma Ltd.
BSE Code 524665
ISIN Demat INE124C01016
Book Value (Rs) 9.73
NSE Code NA
Dividend Yield % 0.00
Market Cap(Rs Mn) 0.00
TTM PE(x) 0.00
TTM EPS(Rs) 0.00
Face Value (Rs) 10  
Particulars Mar 2005Mar 2004Mar 2002Mar 2001Mar 2000
Operational & Financial Ratios          
   Earnings Per Share (Rs)0.00  -0.01  -0.80  -2.53  -1.00  
   CEPS(Rs)0.00  -0.01  -0.56  -2.23  -0.68  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)9.73  9.73  3.08  3.70  6.06  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)3.10  0  -60.95  -2701.87  -381.58  
   EBIT Margin(%)-2.84  0  -75.84  -2965.18  -568.68  
   Pre Tax Margin(%)-2.84  0  -92.05  -3149.32  -668.91  
   PAT Margin (%)-2.84  0  -92.05  -3149.32  -668.91  
   Cash Profit Margin (%)3.10  0  -65.17  -2766.38  -451.90  
Performance Ratios          
   ROA(%)-0.03  -0.30  -13.40  -32.58  -10.59  
   ROE(%)-0.03  -0.30  -23.53  -51.92  -15.48  
   ROCE(%)-0.03  -0.30  -14.17  -37.22  -10.41  
   Asset Turnover(x)0.01  0.00  0.15  0.01  0.02  
   Sales/Fixed Asset(x)0.73  0.00  0.16  0.01  0.02  
   Working Capital/Sales(x)6.16  0.00  4.97  0.13  0.11  
Efficiency Ratios          
   Fixed Capital/Sales(x)1.36  0  6.22  80.47  48.78  
   Receivable days94.02  0  137.12  18.31  348.05  
   Inventory Days3.75  0  0.00  5090.63  3320.27  
   Payable days64.50  0  239.98  169.63  0.00  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)0.00  -64.82  0.00  -0.45  -5.02  
   Price/Book(x)0.00  0.06  0.00  0.27  0.56  
   Yield(%)0  0.00  0  0.00  0.00  
   EV/Net Sales(x)92.15  0  12.59  26.96  31.41  
   EV/Core EBITDA(x)2972.56  -68.41  -25.72  -1.04  -8.93  
   EV/EBIT(x)-3248.67  -38.84  -16.60  -0.91  -5.52  
   EV/CE(x)1.03  0.06  2.08  0.33  0.53  
   M Cap / Sales0.00  0  0.00  12.42  22.69  
Growth Ratio          
   Net Sales Growth(%)0  -100.00  976.56  -46.29  -92.40  
   Core EBITDA Growth(%)139.77  43.04  79.59  -294.39  21.77  
   EBIT Growth(%)79.34  35.23  72.46  -180.06  11.34  
   PAT Growth(%)79.34  46.64  68.53  -152.88  15.28  
   EPS Growth(%)79.34  98.13  68.53  -152.88  15.28  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.32  0.40  0.26  
   Current Ratio(x)1.96  1.44  1.27  1.83  4.51  
   Quick Ratio(x)1.90  1.44  1.27  0.65  1.10  
   Interest Cover(x)0  0  -4.68  -16.10  -5.67  
   Total Debt/Mcap(x)0  0.06  0  1.50  0.46